We offer training opportunities for investigators and research staff alike, including individual classes in our Master's of Science in Clinical Investigation degree program.

The ACT Network is a real-time platform allowing researchers to explore and validate feasibility for clinical studies across many of the NCATS Clinical and Translational Science Award (CTSA) sites, ...

We're here to help: NUCATS has a broad array of resources and services to assist you. We welcome all inquiries and are equipped to help you in your search for information and resources. Visit the Need ...

Over the past two decades, translational science has become a team-based endeavor that leverages the strengths and expertise of scientists trained in different fields. Successful teams learn through ...

NUCATS’s Center for Education and Career Development hosts multiple programs designed to prepare faculty to be effective and successful in their roles — as a mentee or as a mentor. Workshops are open ...

The Enhancing Quality in the Translational Research Workforce Conference (EQuaTR) offers the opportunity for clinical research staff to learn from leaders in the field, gaining practical knowledge on ...

The Master of Science in Clinical Investigation (MSCI) is a part-time graduate program sponsored by NUCATS. The objective of the MSCI program is to produce clinical scientists who are skilled in ...

The NUCATS Health Informatics and Data Science Collaborative fosters innovation, collaboration, and a sense of community among informaticists at Northwestern University. All are welcome to join, ...

There is an exciting new clinical trial about to launch at Northwestern Medicine that uses an Apple Watch and an iPhone app and could revolutionize the standard of care for many with atrial ...

Below are standardized templates for common regulatory forms and various study logs. For industry studies, your research sponsor may provide a different template. Documents and policies frequently ...

Pediatric cancer research is met with significant challenges: childhood cancers are rare and remain among the most difficult to treat, with survival rates for high-risk cases largely unchanged for ...